CD36 and atherosclerosis: Consistent with its role in chronic inflammatory diseases such as atherosclerosis, CD36 modulation was associated with reduced systemic inflammation and increased differentiation of vascular macrophages towards an M2 anti‐inflammatory phenotype [28, 29, 40].